Next Issue
Volume 3, August
Previous Issue
Volume 3, June
 
 

COVID, Volume 3, Issue 7 (July 2023) – 9 articles

Cover Story (view full-size image): In the past two decades, epidemic viral diseases have created global challenges. Many solutions have been proposed, but public vaccination still represents the most effective strategy. So far, various kinds of vaccines, including protein subunits, virus-like particles, inactivated, live attenuated, viral vectors, RNA, and DNA vaccines, have been used. Among the various categories of vaccines, peptide vaccines have created new hope due to the development of proteomics equipment. This review specifically focuses on vaccines and peptide therapies in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
The efficacy and safety of subunit and synthetic peptides vaccines in clinical trial phases and monoclonal antibodies with the ability to suppress the development of SARS-CoV-2, which entered into clinical trials until March 2023, were evaluated. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
10 pages, 260 KiB  
Article
Associations between Socio-Demographic Characteristics and Maternal Attitudes towards Childhood Vaccination in Cyprus—A Cross-Sectional Survey
by Maria Kyprianidou, Georgia Fakonti, Eleana Tzira, Magdalini Pylli and Konstantinos Giannakou
COVID 2023, 3(7), 1042-1051; https://doi.org/10.3390/covid3070076 - 21 Jul 2023
Cited by 1 | Viewed by 1101
Abstract
Background: As vaccination acceptance is dynamic, the current COVID-19 pandemic may have changed maternal perceptions towards childhood vaccination and influenced their decision to vaccinate their children. This study aimed to examine the associations between socio-demographic characteristics and maternal attitudes towards childhood vaccination at [...] Read more.
Background: As vaccination acceptance is dynamic, the current COVID-19 pandemic may have changed maternal perceptions towards childhood vaccination and influenced their decision to vaccinate their children. This study aimed to examine the associations between socio-demographic characteristics and maternal attitudes towards childhood vaccination at the beginning of the COVID-19 pandemic in Cyprus. Methods: A web-based cross-sectional study was conducted between April and June 2020 using a self-administered survey. Adult mothers with at least one child under the age of 18 were included in this study. Results: Overall, 703 mothers were included, with the majority of them strongly agreeing or agreeing that all vaccinations included in the National Vaccination Program should be available to children (89.3%), recognizing the usefulness of vaccines (91.4%) and their ability to provide protection (90%), acknowledging that the benefits of vaccination outweigh potential risks (86.6%), and being aware that some vaccines may cause adverse reactions (84.1%). Socio-demographic factors, particularly marital status, single-parent status, and employment status, have a significant impact on maternal attitudes and perceptions regarding childhood vaccination. Conclusions: Public health policies should be designed to overcome structural and healthcare system barriers specifically related to socio-demographic factors, ensuring effective and comprehensive strategies to improve childhood vaccination uptake. Full article
11 pages, 6773 KiB  
Brief Report
Extraction-Free RT-PCR Surveillance Testing and Reporting for SARS-CoV-2
by Patrick R. Carney, Tyler Duellman, Jia-Yi Chan, Lauren Wells, Michael Tessmer, Leah Frater-Rubsam, Molly Zeller, Mark Field, James Speers, Kelly Tyrrell, Luke Thompson, Michael Bondurant, Tami Morin, Tamra Dagnon, Brian Goff, Corissa Runde, Sandra Splinter-Bondurant, Charles Konsitzke, Patrick Kelly, Christopher A. Bradfield and Joshua Hymanadd Show full author list remove Hide full author list
COVID 2023, 3(7), 1031-1041; https://doi.org/10.3390/covid3070075 - 21 Jul 2023
Viewed by 1423
Abstract
The COVID-19 pandemic necessitated sensitive, fast, and inexpensive testing for the virus in 2020 prior to the widespread availability of vaccines. Early testing efforts were limited by bottlenecks on reagents, low-throughput testing options, and the slow return of test results. In this paper, [...] Read more.
The COVID-19 pandemic necessitated sensitive, fast, and inexpensive testing for the virus in 2020 prior to the widespread availability of vaccines. Early testing efforts were limited by bottlenecks on reagents, low-throughput testing options, and the slow return of test results. In this paper, we detail the testing pipeline we established at the University of Wisconsin-Madison for rapid, inexpensive, and sensitive surveillance testing for SARS-CoV-2, and we highlight the strengths of the platform that would allow it to be applied to other disease surveillance projects, SARS-CoV-2 variant testing, or future pandemics. This pipeline can be quickly established for further accreditation and clinical application. Full article
Show Figures

Figure 1

7 pages, 265 KiB  
Opinion
Does Long COVID Exist in Sub-Saharan Africa?
by Natasha Mehta, Chiratidzo E. Ndhlovu and Tariro Makadzange
COVID 2023, 3(7), 1024-1030; https://doi.org/10.3390/covid3070074 - 17 Jul 2023
Viewed by 1319
Abstract
Billions of people have been impacted by the SARS-CoV-2 pandemic with over 600 million infections worldwide. Researchers have turned their attention to describing the post-viral phenomenon known commonly as “Long COVID”. While post-viral syndromes have been documented after other viral pandemics, the scale [...] Read more.
Billions of people have been impacted by the SARS-CoV-2 pandemic with over 600 million infections worldwide. Researchers have turned their attention to describing the post-viral phenomenon known commonly as “Long COVID”. While post-viral syndromes have been documented after other viral pandemics, the scale of the SARS-CoV-2 pandemic provides a unique opportunity to study and understand both the epidemiology and pathophysiology of the long COVID syndrome. While the pandemic impacted populations from all continents, there is a significant gap in what is known about long COVID on the sub-Saharan African continent. We review what is known about long COVID and highlight the need for further research within the African population. Full article
13 pages, 454 KiB  
Article
Training Modifications in Endurance Athletes Due to COVID-19 Restrictions
by Birinder Singh Nijjar, Meena Shah, Kamiah Moss, Andreas Kreutzer, Austin J. Graybeal, Robyn Braun-Trocchio, Yan Zhang and Ryan R. Porter
COVID 2023, 3(7), 1011-1023; https://doi.org/10.3390/covid3070073 - 12 Jul 2023
Viewed by 1140
Abstract
The aim of this study was to determine which characteristics of recreational, collegiate, and professional endurance athletes were associated with training changes due to COVID-19 safety restrictions. A Qualtrics survey was distributed to endurance athletes around the world from June 2020 to February [...] Read more.
The aim of this study was to determine which characteristics of recreational, collegiate, and professional endurance athletes were associated with training changes due to COVID-19 safety restrictions. A Qualtrics survey was distributed to endurance athletes around the world from June 2020 to February 2021. Significant differences between athlete characteristics and changes in training status were determined using a Chi-squared test (significance p < 0.05). Approximately 66% of the 331 endurance athletes changed their training due to restrictions. Significant group differences were found for age, sex, prior coaching status, prior use of a training program, and athlete primary sport compared to the whole sample. Understanding these factors may allow athletes/coaches to approach training in a different way to help minimize or prevent the effects of detraining for a greater portion of athletes should a COVID-19 variant or any other pandemic emerge in the future. Full article
12 pages, 1810 KiB  
Article
Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study
by Mankgopo Kgatle, Joseph Musonda Chalwe, Donald van der Westhuizen, Shuting Xu, Botle Precious Damane, Precious Mathebela, Veronica Ueckermann, Simnikiwe Mayaphi, Hosana Gomes Rodrigues, Pedro Moura-Alves, Honest Ndlovu, Yonwaba Mzizi, Lusanda Zongo, Henry Hairwadzi, Mariza Vorster, Jan Rijn Zeevaart and Mike Sathekge
COVID 2023, 3(7), 999-1010; https://doi.org/10.3390/covid3070072 - 3 Jul 2023
Viewed by 1966
Abstract
A correlation between neutralization activity after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and protection against coronavirus disease 2019 (COVID-19) has been demonstrated by several studies. Here, we detect SARS-CoV-2 neutralizing antibody (NAB) production in COVID-19 patients from the Steve Biko Academic [...] Read more.
A correlation between neutralization activity after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and protection against coronavirus disease 2019 (COVID-19) has been demonstrated by several studies. Here, we detect SARS-CoV-2 neutralizing antibody (NAB) production in COVID-19 patients from the Steve Biko Academic Hospital complex (SBAH), South Africa (SA). Samples from COVID-19 patients (mild to severe) were collected. SARS-CoV-2 rapid assays, genotyping (Delta and Omicron variants) and enzyme-linked immunosorbent assays (ELISA) were performed. IBM® Statistical Package for the Social Sciences (SPSS®) version 28 was used for inferential statistical analysis, and the data were presented using the Prism9 software (version 9.4.1). A total of 137 laboratory-confirmed COVID-19 patients, 12 vaccine recipients and 8 unvaccinated participants were evaluated. The production of SARS-CoV-2 NABs was observed in some of the COVID-19 cases, mainly in severe cases, although this should be noted with caution due to the small sample size of this pilot study. NABs were also observed in asymptomatic participants, with the most being found in recipients (n = 6) of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. We found a strong presence of NABs in COVID-19 patients, specifically in mild and severe cases. Severe infection was associated with higher NAB production (82%). Full article
(This article belongs to the Special Issue Immune Responses in Coronavirus Disease)
Show Figures

Figure 1

12 pages, 865 KiB  
Review
Home Isolation and Online Support Strategies during Mild COVID-19 Pandemic Waves in Thailand: A Scoping Review
by Bonggochpass Pinsawas, Suphawan Ophakas, Anan Bedavanija, Wanwalee Kochasawas, Phakamas Jitpun, Suree Leemongkol, Pochamana Phisalprapa, Weerachai Srivanichakorn, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Rungsima Tinmanee, Naruemit Sayabovorn, Cherdchai Nopmaneejumruslers, Methee Chayakulkeeree, Pakpoom Phoompoung, Gornmigar Sanpawitayakul, Rungsima Wanitphakdeedecha, Saipin Muangman, Visit Vamvanij, Korapat Mayurasakorn and on behalf of the SPHERE Groupadd Show full author list remove Hide full author list
COVID 2023, 3(7), 987-998; https://doi.org/10.3390/covid3070071 - 30 Jun 2023
Viewed by 1452
Abstract
Objectives: In 2021, Thailand experienced its fourth and fifth waves of COVID-19, overwhelming the nation’s public health system. The significant gap between health resources and the demand for services from patients was one of the primary challenges in responding to the catastrophic COVID-19 [...] Read more.
Objectives: In 2021, Thailand experienced its fourth and fifth waves of COVID-19, overwhelming the nation’s public health system. The significant gap between health resources and the demand for services from patients was one of the primary challenges in responding to the catastrophic COVID-19 pandemic. Hospitals were inundated with a surge in new patients, leading to a growing backlog of individuals suffering delayed care or even rejection from the healthcare system. To tackle this issue, strategies such as “outpatient self-isolation” (SI), “home-based isolation” (HI), and “community-based isolation” (CI) were implemented to stabilize COVID-19 cases with mild to moderate symptoms. This review aimed to explore the experiences in the management of COVID-19 care in patients with mild to moderate symptoms and identify challenges after the initial response of the Thailand health system to the pandemic. Methods: This study was conducted during the Delta pandemic (June–November 2021) and the Omicron pandemic (December 2021–15 March 2022). We present the lessons learned from the management of the HI system based on experiences gained at a university hospital, which provided remote professional-to-patient support during the pandemic. The study involved retrospective data from electronic medical records and qualitative analysis of responses provided during the pandemic using the HI system. Results: Data from a total of 2704 and 1912 participants were included in the analysis. The vast majority of patients were assigned to HI immediately after being diagnosed with COVID-19. This system facilitated remote consultations, provision of necessary medications, and delivery of survival kits to patients’ homes. Qualitative reviews indicated several key factors that could contribute to successful COVID-19 management under the HI system: (1) effective management and vaccine status, (2) establishment of home isolation using the find-test-trace-isolate-support system, and (3) adherence to home isolation guidelines and system support. Challenges included the digitalization of tools for securing isolation, team preparedness and adequate support system during HI, as well as hospital policies for psychological support for healthcare workers and measures to alleviate their workload. Conclusions: Our investigation suggests that the HI teleconsultation system was an effective approach to managing COVID-19. It allowed for a prompt response to patients’ needs and provided timely access to medical support, particularly for individuals with mild to moderate symptoms. Full article
Show Figures

Figure 1

12 pages, 1324 KiB  
Review
Harnessing Antiviral Peptides as Means for SARS-CoV-2 Control
by Khatereh Zarkesh, Mohsen Akbarian, Lobat Tayebi, Vladimir N. Uversky, Alberto Rubio-Casillas and Elrashdy M. Redwan
COVID 2023, 3(7), 975-986; https://doi.org/10.3390/covid3070070 - 29 Jun 2023
Viewed by 1372
Abstract
Several times during the past two decades, epidemic viral diseases created global challenges. Although many solutions have been proposed to deal with this tight spot, it is still believed that public vaccination represents the most effective strategy to handle it. So far, various [...] Read more.
Several times during the past two decades, epidemic viral diseases created global challenges. Although many solutions have been proposed to deal with this tight spot, it is still believed that public vaccination represents the most effective strategy to handle it. So far, various kinds of vaccines including protein subunits, virus-like particles, inactivated, live attenuated, viral vectors, RNA, and DNA vaccines have been used in the prevention of COVID-19. Among the various categories of vaccines, peptide vaccines have created a new hope for quick and trustworthy access due to the development of proteomics equipment. This review specifically focuses on vaccines and peptide therapies in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We consider here the efficacy and safety of subunit and synthetic peptides vaccine in clinical trial phases. Furthermore, monoclonal antibodies with the ability to suppress the development of SARS-CoV-2, those candidates that have entered into clinical trials until March 2023, were selected and evaluated. Full article
Show Figures

Figure 1

19 pages, 3207 KiB  
Article
Assessing COVID-19 Effects on Inflation, Unemployment, and GDP in Africa: What Do the Data Show via GIS and Spatial Statistics?
by Butte Gotu and Habte Tadesse
COVID 2023, 3(7), 956-974; https://doi.org/10.3390/covid3070069 - 28 Jun 2023
Viewed by 2621
Abstract
What are the effects of Corona Virus Disease 19 (COVID-19) on inflation, unemployment, and GDP in Africa? Using geo-coded cross-sectional data taken from the World Health Organization and International Monetary Fund, we investigate the spatial distribution of COVID-19 and its effects on inflation, [...] Read more.
What are the effects of Corona Virus Disease 19 (COVID-19) on inflation, unemployment, and GDP in Africa? Using geo-coded cross-sectional data taken from the World Health Organization and International Monetary Fund, we investigate the spatial distribution of COVID-19 and its effects on inflation, unemployment, and Gross Domestic Product (GDP) in Africa by employing the Geographic Information System (GIS), multivariate analysis of covariance (MANCOVA), and spatial statistics. The entire dataset was analyzed using Stata, ArcGIS, and R software. The result shows (1) that there is evidence of a spatial pattern of COVID-19 cases and death rate clustering behavior in Africa, verifying the existence of spatial autocorrelation. The result also reveals (2) that COVID-19 has a negative effect on unemployment, inflation, and GDP in Africa. We confirmed that (3) temperature, rainfall, and humidity were statistically significantly associated with the spread of the COVID-19 pandemic in Africa. The comparison of the GDP of African countries before and after the pandemic shows (4) a large decrease in GDP, the highest in Seychelles (23 percent). The result of the study shows (5) that there has been a significant increase in inflation and unemployment rates in all countries since the outbreak of the pandemic as compared to the time before the outbreak. There is also evidence that (6) there is a significant relationship between death rate due to COVID-19 and population density; temperature with COVID-19 cases and death rate; and precipitation with death rate due to COVID-19. Therefore, respective governments and the international community need to pay attention to controlling/reducing the impact of COVID-19 on inflation, unemployment, and GDP, focusing on the indicated demographic and environmental variables. Full article
(This article belongs to the Special Issue Analysis of Modeling and Statistics for COVID-19)
Show Figures

Figure 1

19 pages, 472 KiB  
Article
Agent-Based Modeling to Simulate Aerosolized Transmission of SARS-CoV-2 inside Small Ventilated Spaces
by Matthew Gaddis, Valipuram Manoranjan and Jakob Streipel
COVID 2023, 3(7), 937-955; https://doi.org/10.3390/covid3070068 - 24 Jun 2023
Viewed by 818
Abstract
Deterministic and stochastic models for aerosol virus spread have become aplenty in the last several years. We believe it is important to explore all avenues of models and look to expand the current repertoire of models in this domain using a simple stochastic [...] Read more.
Deterministic and stochastic models for aerosol virus spread have become aplenty in the last several years. We believe it is important to explore all avenues of models and look to expand the current repertoire of models in this domain using a simple stochastic agent-based method. The goal is to understand if this type of agent model is applicable to real-life scenarios and to discuss possible policy implications of our findings on disease spread through aerosols in small spaces with ventilation using our developed model. We apply our agent model to see how different spatial organizations of an infected individual impact infections and their distributions. We also perform some sensitivity analysis with regard to both how different vectors of infection change overall infectivity rates but also how different levels of ventilation and filtration can impact infectivity as well. Our findings show that the simple stochastic movement of particles should be explored further with regard to agent-based disease spread models, and that filtration plays a large role in determining the overall infection rate of people in small spaces with an infector. We also found that placement of the index infector with regard to other susceptible people and ventilation play an impactful role in how a disease may spread in a short time frame within small confines. Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop